Loading...
Header Logo
Keywords
Last Name
Institution

JIANHUA LING

TitleInstructor
InstitutionMD Anderson
DepartmentMolecular & Cellular Oncology
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Ling J, Chiao PJ. Two Birds with One Stone: Therapeutic Targeting of IL1a Signaling Pathways in Pancreatic Ductal Adenocarcinoma and the Cancer-Associated Fibroblasts. Cancer Discov. 2019 Feb; 9(2):173-175. PMID: 30737215.
      View in: PubMed
    2. Zhou L, Husted H, Moore T, Lu M, Deng D, Liu Y, Ramachandran V, Arumugam T, Niehrs C, Wang H, Chiao P, Ling J, Curran MA, Maitra A, Hung MC, Lee JE, Logsdon CD, Hwang RF. Suppression of stromal-derived Dickkopf-3 (DKK3) inhibits tumor progression and prolongs survival in pancreatic ductal adenocarcinoma. Sci Transl Med. 2018 10 24; 10(464). PMID: 30355799.
      View in: PubMed
    3. Zhang Y, Zoltan M, Riquelme E, Xu H, Sahin I, Castro-Pando S, Montiel MF, Chang K, Jiang Z, Ling J, Gupta S, Horne W, Pruski M, Wang H, Sun SC, Lozano G, Chiao P, Maitra A, Leach SD, Kolls JK, Vilar E, Wang TC, Bailey JM, McAllister F. Immune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells. Gastroenterology. 2018 07; 155(1):210-223.e3. PMID: 29604293.
      View in: PubMed
    4. Zhuang Z, Li H, Lee H, Aguilar M, Gocho T, Ju H, Iida T, Ling J, Fu J, Wu M, Sun Y, Lu Y, Chiao PJ. NEMO peptide inhibits the growth of pancreatic ductal adenocarcinoma by blocking NF-?B activation. Cancer Lett. 2017 12 28; 411:44-56. PMID: 28951128.
      View in: PubMed
    5. Chiao PJ, Ling J, Fu J, Lu Y, Sun YC. Inhibition of Pancreatic Cancer by RhIL1RA-Response. Clin Cancer Res. 2017 06 15; 23(12):3224. PMID: 28620001.
      View in: PubMed
    6. Kang Y, Roife D, Lee Y, Lv H, Suzuki R, Ling J, Rios Perez MV, Li X, Dai B, Pratt M, Truty MJ, Chatterjee D, Wang H, Thomas RM, Wang Y, Koay EJ, Chiao PJ, Katz MH, Fleming JB. Transforming Growth Factor-ß Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocarcinoma Tumors. Clin Cancer Res. 2016 Oct 01; 22(19):4934-4946. PMID: 27126993.
      View in: PubMed
    7. Zhuang Z, Ju HQ, Aguilar M, Gocho T, Li H, Iida T, Lee H, Fan X, Zhou H, Ling J, Li Z, Fu J, Wu M, Li M, Melisi D, Iwakura Y, Xu K, Fleming JB, Chiao PJ. IL1 Receptor Antagonist Inhibits Pancreatic Cancer Growth by Abrogating NF-?B Activation. Clin Cancer Res. 2016 Mar 15; 22(6):1432-44. PMID: 26500238.
      View in: PubMed
    8. Kang Y, Ling J, Suzuki R, Roife D, Chopin-Laly X, Truty MJ, Chatterjee D, Wang H, Thomas RM, Katz MH, Chiao PJ, Fleming JB. SMAD4 regulates cell motility through transcription of N-cadherin in human pancreatic ductal epithelium. PLoS One. 2014; 9(9):e107948. PMID: 25264609.
      View in: PubMed
    9. Chang Z, Ju H, Ling J, Zhuang Z, Li Z, Wang H, Fleming JB, Freeman JW, Yu D, Huang P, Chiao PJ. Cooperativity of oncogenic K-ras and downregulated p16/INK4A in human pancreatic tumorigenesis. PLoS One. 2014; 9(7):e101452. PMID: 25029561.
      View in: PubMed
    10. Yang J, He J, Wang J, Cao Y, Ling J, Qian J, Lu Y, Li H, Zheng Y, Lan Y, Hong S, Matthews J, Starbuck MW, Navone NM, Orlowski RZ, Lin P, Kwak LW, Yi Q. Constitutive activation of p38 MAPK in tumor cells contributes to osteolytic bone lesions in multiple myeloma. Leukemia. 2012 Sep; 26(9):2114-23. PMID: 22425892.
      View in: PubMed
    11. Ling J, Kang Y, Zhao R, Xia Q, Lee DF, Chang Z, Li J, Peng B, Fleming JB, Wang H, Liu J, Lemischka IR, Hung MC, Chiao PJ. KrasG12D-induced IKK2/ß/NF-?B activation by IL-1a and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell. 2012 Jan 17; 21(1):105-20. PMID: 22264792.
      View in: PubMed
    12. Melisi D, Xia Q, Paradiso G, Ling J, Moccia T, Carbone C, Budillon A, Abbruzzese JL, Chiao PJ. Modulation of pancreatic cancer chemoresistance by inhibition of TAK1. J Natl Cancer Inst. 2011 Aug 03; 103(15):1190-204. PMID: 21743023.
      View in: PubMed
    13. Chiao PJ, Ling J. Kras, Pten, NF-?B, and inflammation: dangerous liaisons. Cancer Discov. 2011 Jul; 1(2):103-5. PMID: 22586351.
      View in: PubMed
    14. Peng B, Ling J, Lee AJ, Wang Z, Chang Z, Jin W, Kang Y, Zhang R, Shim D, Wang H, Fleming JB, Zheng H, Sun SC, Chiao PJ. Defective feedback regulation of NF-kappaB underlies Sjogren's syndrome in mice with mutated kappaB enhancers of the IkappaBalpha promoter. Proc Natl Acad Sci U S A. 2010 Aug 24; 107(34):15193-8. PMID: 20696914.
      View in: PubMed
    15. Pi W, Zhu X, Wu M, Wang Y, Fulzele S, Eroglu A, Ling J, Tuan D. Long-range function of an intergenic retrotransposon. Proc Natl Acad Sci U S A. 2010 Jul 20; 107(29):12992-7. PMID: 20615953.
      View in: PubMed
    16. Melisi D, Ossovskaya V, Zhu C, Rosa R, Ling J, Dougherty PM, Sherman BM, Abbruzzese JL, Chiao PJ. Oral poly(ADP-ribose) polymerase-1 inhibitor BSI-401 has antitumor activity and synergizes with oxaliplatin against pancreatic cancer, preventing acute neurotoxicity. Clin Cancer Res. 2009 Oct 15; 15(20):6367-77. PMID: 19808866.
      View in: PubMed
    17. Ling JJ, Wang Y, Xie B, Zhou LL. [Bioequivalence study of sinomenine patch by microdialysis]. Zhongguo Zhong Yao Za Zhi. 2008 Nov; 33(21):2482-5. PMID: 19149253.
      View in: PubMed
    18. Ling JJ, Xie B, Wang Y, Zhou LL. [Dynamic determination of sinomenine in skin by microdialysis]. Zhong Yao Cai. 2008 Jul; 31(7):1062-5. PMID: 18973024.
      View in: PubMed
    19. Zhu X, Ling J, Zhang L, Pi W, Wu M, Tuan D. A facilitated tracking and transcription mechanism of long-range enhancer function. Nucleic Acids Res. 2007; 35(16):5532-44. PMID: 17704132.
      View in: PubMed
    20. Ricci MS, Kim SH, Ogi K, Plastaras JP, Ling J, Wang W, Jin Z, Liu YY, Dicker DT, Chiao PJ, Flaherty KT, Smith CD, El-Deiry WS. Reduction of TRAIL-induced Mcl-1 and cIAP2 by c-Myc or sorafenib sensitizes resistant human cancer cells to TRAIL-induced death. Cancer Cell. 2007 Jul; 12(1):66-80. PMID: 17613437.
      View in: PubMed
    21. Zhou LL, Wang Y, Liu QF, Ling JJ. [Study on determination of entrapment efficiency of sinomenine liposomes]. Zhongguo Zhong Yao Za Zhi. 2006 May; 31(9):731-4. PMID: 17048678.
      View in: PubMed
    22. Yu X, Zhu X, Pi W, Ling J, Ko L, Takeda Y, Tuan D. The long terminal repeat (LTR) of ERV-9 human endogenous retrovirus binds to NF-Y in the assembly of an active LTR enhancer complex NF-Y/MZF1/GATA-2. J Biol Chem. 2005 Oct 21; 280(42):35184-94. PMID: 16105833.
      View in: PubMed
    23. Ling J, Baibakov B, Pi W, Emerson BM, Tuan D. The HS2 enhancer of the beta-globin locus control region initiates synthesis of non-coding, polyadenylated RNAs independent of a cis-linked globin promoter. J Mol Biol. 2005 Jul 29; 350(5):883-96. PMID: 15979088.
      View in: PubMed
    24. Ling J, Ainol L, Zhang L, Yu X, Pi W, Tuan D. HS2 enhancer function is blocked by a transcriptional terminator inserted between the enhancer and the promoter. J Biol Chem. 2004 Dec 03; 279(49):51704-13. PMID: 15465832.
      View in: PubMed
    25. Ling J, Zhang L, Jin H, Pi W, Kosteas T, Anagnou NP, Goodman M, Tuan D. Dynamic retrotransposition of ERV-9 LTR and L1 in the beta-globin gene locus during primate evolution. Mol Phylogenet Evol. 2004 Mar; 30(3):867-71. PMID: 15012967.
      View in: PubMed
    26. Xu KP, Ding Y, Ling J, Dong Z, Yu FS. Wound-induced HB-EGF ectodomain shedding and EGFR activation in corneal epithelial cells. Invest Ophthalmol Vis Sci. 2004 Mar; 45(3):813-20. PMID: 14985295.
      View in: PubMed
    27. Pi W, Yang Z, Wang J, Ruan L, Yu X, Ling J, Krantz S, Isales C, Conway SJ, Lin S, Tuan D. The LTR enhancer of ERV-9 human endogenous retrovirus is active in oocytes and progenitor cells in transgenic zebrafish and humans. Proc Natl Acad Sci U S A. 2004 Jan 20; 101(3):805-10. PMID: 14718667.
      View in: PubMed
    28. Ling J, Pi W, Yu X, Bengra C, Long Q, Jin H, Seyfang A, Tuan D. The ERV-9 LTR enhancer is not blocked by the HS5 insulator and synthesizes through the HS5 site non-coding, long RNAs that regulate LTR enhancer function. Nucleic Acids Res. 2003 Aug 01; 31(15):4582-96. PMID: 12888519.
      View in: PubMed
    29. Ling J, Pi W, Bollag R, Zeng S, Keskintepe M, Saliman H, Krantz S, Whitney B, Tuan D. The solitary long terminal repeats of ERV-9 endogenous retrovirus are conserved during primate evolution and possess enhancer activities in embryonic and hematopoietic cells. J Virol. 2002 Mar; 76(5):2410-23. PMID: 11836419.
      View in: PubMed
    30. Migliaccio AR, Bengra C, Ling J, Pi W, Li C, Zeng S, Keskintepe M, Whitney B, Sanchez M, Migliaccio G, Tuan D. Stable and unstable transgene integration sites in the human genome: extinction of the Green Fluorescent Protein transgene in K562 cells. Gene. 2000 Oct 03; 256(1-2):197-214. PMID: 11054549.
      View in: PubMed
    31. Ling JY, Kienzle TE, Chen TM, Henkel JS, Wright GC, Stroop WG. Comparative analyses of the latency-associated transcript promoters from herpes simplex virus type 1 strains H129, +GC and KOS-63. Virus Res. 1997 Jul; 50(1):95-106. PMID: 9255939.
      View in: PubMed
    32. Ling JY, Kienzle TE, Stroop WG. An improved rapid method for purification of herpes simplex virus DNA using cesium trifluoroacetate. J Virol Methods. 1996 Apr 26; 58(1-2):193-8. PMID: 8783165.
      View in: PubMed
    33. IL1 receptor antagonist inhibits pancreatic cancer growth by abrogating NF-κB activation. Clinical Cancer Research. 22:1432-1444.
    34. Transforming growth factor-β limits secretion of lumican by activated stellate cells within primary pancreatic adenocarcinoma tumors. Clinical Cancer Research. 22:4934-4946.
    LING's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description